The emergence of Fanconi anaemia type S: a phenotypic spectrum of biallelic BRCA1 mutations
BRCA1 is involved in the Fanconi anaemia (FA) pathway, which coordinates repair of DNA interstrand cross-links. FA is a rare genetic disorder characterised by bone marrow failure, cancer predisposition and congenital abnormalities, caused by biallelic mutations affecting proteins in the FA pathway....
Main Authors: | Tirion Hughes, Anna M. Rose |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-12-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1278004/full |
Similar Items
-
Fanconi Anaemia, Childhood Cancer and the <i>BRCA</i> Genes
by: Emma R. Woodward, et al.
Published: (2021-09-01) -
Inhibitors of the Fanconi anaemia pathway as potential antitumour agents for ovarian cancer
by: Sarah J Taylor, et al.
Published: (2020-02-01) -
Clinical Vignette: Early-Onset Head and Neck Cancer: Beware of Fanconi Anaemia!
by: Sijmons Rolf H, et al.
Published: (2004-07-01) -
Biallelic germline BRCA1 mutations in a patient with early onset breast cancer, mild Fanconi anemia‐like phenotype, and no chromosome fragility
by: Katharina Keupp, et al.
Published: (2019-09-01) -
Vulvar carcinoma in Fanconi Anaemia: A case report with review of literature
by: Vysakh Visweswaran, et al.
Published: (2021-08-01)